| Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–2017 Z Chen, L Xu, W Shi, F Zeng, R Zhuo, X Hao, P Fan Breast cancer research and treatment 180, 481-490, 2020 | 127 | 2020 |
| A machine learning model to predict the triple negative breast cancer immune subtype Z Chen, M Wang, RL De Wilde, R Feng, M Su, LA Torres-de la Roche, ... Frontiers in immunology 12, 749459, 2021 | 38 | 2021 |
| Less expression of CD4+ and CD8+ T cells might reflect the severity of infection and predict worse prognosis in patients with COVID-19: Evidence from a pooled analysis D Hu, L Li, W Shi, L Zhang Clinica Chimica Acta 510, 1-4, 2020 | 33 | 2020 |
| Global, regional, and national mortality trends of female breast cancer by risk factor, 1990–2017 H Liu, W Shi, Z Jin, R Zhuo, J Dong, Q Lao, S Li, W Pang BMC cancer 21 (1), 459, 2021 | 31 | 2021 |
| Sensory ion channel candidates inform on the clinical course of pancreatic cancer and present potential targets for repurposing of FDA-approved agents W Shi, C Li, T Wartmann, C Kahlert, R Du, A Perrakis, T Brunner, ... Journal of Personalized Medicine 12 (3), 478, 2022 | 22 | 2022 |
| Prognostic value of genes and immune infiltration in prostate tumor microenvironment W Sun, H Shi, Z Yuan, L Xia, X Xiang, X Quan, W Shi, L Jiang Frontiers in Oncology 10, 584055, 2020 | 20 | 2020 |
| COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation W Shi, Z Chen, H Liu, C Miao, R Feng, G Wang, G Chen, Z Chen, P Fan, ... Frontiers in Immunology 13, 937125, 2022 | 19 | 2022 |
| Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network D Hu, B Zhang, M Yu, W Shi, L Zhang Molecular medicine reports 22 (2), 620-632, 2020 | 19 | 2020 |
| Five-mRNA signature for the prognosis of breast cancer based on the ceRNA network W Shi, D Hu, S Lin, R Zhuo BioMed Research International 2020, 2020 | 18 | 2020 |
| Breast cancer survival prediction using seven prognostic biomarker genes L Liu, Z Chen, W Shi, H Liu, W Pang Oncology letters 18 (3), 2907-2916, 2019 | 17 | 2019 |
| Construction of ceRNA networks associated with CD8 T cells in breast cancer Z Chen, R Feng, UD Kahlert, Z Chen, LA Torres-dela Roche, A Soliman, ... Frontiers in Oncology 12, 883197, 2022 | 16 | 2022 |
| Identification of cancer-associated fibroblast subtype of triple-negative breast cancer M Wang, R Feng, Z Chen, W Shi, C Li, H Liu, K Wu, D Li, X Li Journal of Oncology 2022, 2022 | 16 | 2022 |
| High WDR34 mRNA expression as a potential prognostic biomarker in patients with breast cancer as determined by integrated bioinformatics analysis DJ Hu, WJ Shi, M Yu, L Zhang Oncology Letters 18 (3), 3177-3187, 2019 | 14 | 2019 |
| Evaluation of the benefit of post‑mastectomy radiotherapy in patients with early‑stage breast cancer: A propensity score matching study W Shi, Y Luo, D Zhao, H Huang, W Pang Oncology letters 17 (6), 4851-4858, 2019 | 14 | 2019 |
| PSRR: a web server for predicting the regulation of miRNAs expression by small molecules F Yu, B Li, J Sun, J Qi, RL De Wilde, LA Torres-de la Roche, C Li, ... Frontiers in Molecular Biosciences 9, 817294, 2022 | 13 | 2022 |
| Optimizing chemotherapy of pancreatic acinar cell carcinoma: our experiences and pooled analysis of literature JY Xu, WL Guan, SX Lu, XL Wei, WJ Shi, C Ren, YH Li, SP Li, MZ Qiu, ... Clinical Medicine Insights: Oncology 16, 11795549221090186, 2022 | 11 | 2022 |
| Artificial ovary for young female breast cancer patients J Chen, LA Torres-de la Roche, UD Kahlert, V Isachenko, H Huang, ... Frontiers in Medicine 9, 837022, 2022 | 10 | 2022 |
| Mendelian Randomization Analyses of Chronic Immune-Mediated Diseases, Circulating Inflammatory Biomarkers, and Cytokines in Relation to Liver Cancer Q Yin, Q Yang, W Shi, UD Kahlert, Z Li, S Lin, Q Song, W Fan, L Wang, ... Cancers 15 (11), 2930, 2023 | 9 | 2023 |
| Ovarian tissue bank for fertility preservation and anti-menopause hormone replacement J Chen, Y Han, W Shi, X Yan, Y Shi, Y Yang, H Gao, Y Li Frontiers in Endocrinology 13, 950297, 2022 | 9 | 2022 |
| COL10A1 allows stratification of invasiveness of colon Cancer and associates to extracellular matrix and immune cell enrichment in the Tumor parenchyma UD Kahlert, W Shi, M Strecker, LA Scherpinski, T Wartmann, M Dölling, ... Frontiers in Oncology 12, 1007514, 2022 | 6 | 2022 |
